Risk Of Developing Liver Cancer After HCV Treatment

Tuesday, November 22, 2016

Hep C Treatment Prognosis Continues to Amaze

American College of Gastroenterology (ACG) 2016 Annual Scientific Meeting


Hep C Treatment Prognosis Continues to Amaze
Damian McNamara
November 22, 2016

LAS VEGAS — Rapid advances in the treatment of hepatitis C have clinicians seeing outcomes they never thought possible, and experts are optimistic that more complex and challenging patients will respond to therapy.

However, treatment choice can be tricky. And caveats are emerging, including reports that direct-acting antivirals used for the treatment of hepatitis C might increase the risk for hepatitis B reactivation and liver cancer in some patients.

But the big picture is one of clinical success. "We know that 95% to 100% of patients treated for hepatitis C can be cured. It's pretty amazing," said Tram Tran, MD, from the Cedars–Sinai Medical Center and the University of California at Los Angeles.

Continue reading @ Medscape

Of Interest
Nov 21, 2016
NATAP ​- Reported by Jules Levin
New HCV Drugs at AASLD
Key presentations of new HCV DAA regimens

No comments:

Post a Comment